This conference aims to bridge nanotechnology with clinical and pre-clinical cancer research, and to highlight recent applications in patient care. It will provide an overview of the latest developments in the field of cancer-related nanotechnologies. There will be many opportunities to present work, with lively poster sessions and eight proffered papers selected from submitted abstracts.
Topics to be covered
Nanomedicine for effective delivery of siRNA, mRNA, CRISPR-Cas9, and others
Exosomes in cancer theranostics
Detection and combined treatments of early stage disease
Nanomedicine and cancer immunotherapy
Deadline for abstract submission: July 1, 2019.
All COSTers are invited to attend and contribute to this important meeting, organized by the European Association for Cancer Research (EACR). Conference website and program are available on this page.